If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
Company Focused On Advancing Breakthrough Medical Programs in Gene Therapy CAMBRIDGE, Mass.–(HSMN NewsFeed)–Genetix Pharmaceuticals, a major gene therapy company developing breakthrough treatments for severe genetic disorders, announced today that …
Biopharmaceuticals, Venture Capital
Genetix Pharmaceuticals
Posts on ‘March 11th, 2010’
Genetix Pharmaceuticals Secures $35M in Series B Funding
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
WAYNE, N.J., March 11 (HSMN NewsFeed) — Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for ciprofloxacin dry powder inhaler (DPI) for management of pulmona…
Biopharmaceuticals, FDA
Bayer HealthCare Pharmaceuticals, ciprofloxacin dry powder
Portola Pharmaceuticals Announces Senior Management and Board Changes
SOUTH SAN FRANCISCO, Calif., March 11 (HSMN NewsFeed) — Portola Pharmaceuticals, Inc. today announced that Charles Homcy, M.D., president and chief executive officer, will retire from his current job and assume the role of co-chairman of the board …
Biopharmaceuticals, Personnel
Portola Pharmaceuticals
sanofi-aventis Successfully Completes the Acquisition of Chattem, Inc.
ARIS, France, March 11 (HSMN NewsFeed) - sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has completed its acquisition of 100% of Chattem, Inc., which is now a wholly-owned subsidiary of the sanofi-aventis Group. By strengthening it…
Biopharmaceuticals, Mergers & Acquisitions
sanofi-aventis, Chattem, Allegra, fexofenadine
New Hip Implant Provides Personalized Fit
Zimmer Introduces the Continuum(TM) Acetabular System WARSAW, Ind., March 11 (HSMN NewsFeed) — Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal care, today showcased its recently introduced Continuum Acetabular Cup System at t…
Devices, Orthopaedic
Zimmer Holdings, Continuum Acetabular Cup, total hip
New Introducer Product Line from St. Jude Laboratory Offers Reliable Access and Facilitates Arterial Closure
Engage Family offers physicians state-of-the-art introducers capable of facilitating both femoral and radial access ST. PAUL, Minn.–(HSMN NewsFeed)–St. Jude Pharma, Inc. (NYSE:STJ ) today announced U.S. Food and Drug Administration (FDA) clearance an…
Devices, Interventional, FDA, Regulatory
St. Jude Pathology, Engage TR Introducer, Engage Introducer
FDA Approves Boston Scientific’s Express(R) LD Iliac Stent System
First and only premounted, balloon-expandable stent approved specifically for use in iliac arteries NATICK, Mass., March 11 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE:BSX ) today announced that the U.S. Food and Drug Administration (FDA) h…
Devices, Interventional, FDA
Boston Scientific, Express LD, Iliac Premounted Stent, iliac stent
